{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:06:29Z","timestamp":1788545189867,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s11060-008-9781-4","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T14:24:53Z","timestamp":1232720693000},"page":"349-354","source":"Crossref","is-referenced-by-count":125,"title":["Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study"],"prefix":"10.1007","volume":"93","author":[{"given":"Daniel A.","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phiroz","family":"Tarapore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene","family":"Burt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenna","family":"Chakalian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Barbaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen R.","family":"Lamborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,1,24]]},"reference":[{"key":"9781_CR1","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/WNL.54.10.1886","volume":"54","author":"MJ Glantz","year":"2000","unstructured":"Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, Grossman SA, Cairncross JG (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy Of Neurology. Neurology 54:1886\u20131893","journal-title":"Neurology"},{"key":"9781_CR2","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ana.10712","volume":"54","author":"M Klein","year":"2003","unstructured":"Klein M, Engelberts NH, van der Ploeg HM, Kasteleijn-Nolst Trenite DG, Aaronson NK, Taphoorn MJ, Baaijen H, Vandertop WP, Muller M, Postma TJ, Heimans JJ (2003) Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol 54:514\u2013520. doi: 10.1002\/ana.10712","journal-title":"Ann Neurol"},{"key":"9781_CR3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0733-8619(05)70021-9","volume":"19","author":"KD Holland","year":"2001","unstructured":"Holland KD (2001) Efficacy, pharmacology, and adverse effects of antiepileptic drugs. Neurol Clin 19:313\u2013345. doi: 10.1016\/S0733-8619(05)70021-9","journal-title":"Neurol Clin"},{"key":"9781_CR4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0733-8619(05)70005-0","volume":"19","author":"SC Schachater","year":"2001","unstructured":"Schachater SC (2001) Epilepsy. Neurol Clin 19:57\u201378. doi: 10.1016\/S0733-8619(05)70005-0","journal-title":"Neurol Clin"},{"key":"9781_CR5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00001622-200205000-00008","volume":"14","author":"PY Wen","year":"2002","unstructured":"Wen PY, Marks PW (2002) Medical management of patients with brain tumors. Curr Opin Oncol 14:299\u2013307. doi: 10.1097\/00001622-200205000-00008","journal-title":"Curr Opin Oncol"},{"key":"9781_CR6","doi-asserted-by":"crossref","unstructured":"Chang EF, Keles GE, Chang SM, Lamborn KL, Barbaro NM, Berger MS (2005) Seizure characteristics and post-operative seizure control in patients with low-grade gliomas. Congress of Neurological Surgeons (abstract) 2005. Los Angeles, CA, USA","DOI":"10.1093\/neurosurgery\/57.2.430"},{"key":"9781_CR7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF01420191","volume":"103","author":"S Franceschetti","year":"1990","unstructured":"Franceschetti S, Binelli S, Casazza M, Lodrini S, Panzica F, Pluchino F, Solero CL, Avanzini G (1990) Influence of surgery and antiepileptic drugs on seizures symptomatic of cerebral tumours. Acta Neurochir (Wien) 103:47\u201351. doi: 10.1007\/BF01420191","journal-title":"Acta Neurochir (Wien)"},{"key":"9781_CR8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3171\/JNS\/2008\/108\/2\/0227","volume":"108","author":"EF Chang","year":"2008","unstructured":"Chang EF, Potts MB, Keles GE, Lamborn KR, Chang SM, Barbaro NM, Berger MS (2008) Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg 108:227\u2013235. doi: 10.3171\/JNS\/2008\/108\/2\/0227","journal-title":"J Neurosurg"},{"key":"9781_CR9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3171\/jns.1983.58.5.0672","volume":"58","author":"JB North","year":"1983","unstructured":"North JB, Penhall RK, Hanieh A, Frewin DB, Taylor WB (1983) Phenytoin and postoperative epilepsy. A double-blind study. J Neurosurg 58:672\u2013677","journal-title":"J Neurosurg"},{"key":"9781_CR10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/014107689108400412","volume":"84","author":"MD Shaw","year":"1991","unstructured":"Shaw MD, Foy PM (1991) Epilepsy after craniotomy and the place of prophylactic anticonvulsant drugs: discussion paper. J R Soc Med 84:221\u2013223","journal-title":"J R Soc Med"},{"key":"9781_CR11","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/jnnp.47.10.1087","volume":"47","author":"JB Chalk","year":"1984","unstructured":"Chalk JB, Ridgeway K, Brophy T, Yelland JD, Eadie MJ (1984) Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients. J Neurol Neurosurg Psychiatry 47:1087\u20131090. doi: 10.1136\/jnnp.47.10.1087","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9781_CR12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0002-9343(89)80605-9","volume":"87","author":"SA Grossman","year":"1989","unstructured":"Grossman SA, Sheidler VR, Gilbert MR (1989) Decreased phenytoin levels in patients receiving chemotherapy. Am J Med 87:505\u2013510","journal-title":"Am J Med"},{"key":"9781_CR13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJM196907032810108","volume":"281","author":"EE Werk Jr","year":"1969","unstructured":"Werk EE Jr, Choi Y, Sholiton L, Olinger C, Haque N (1969) Interference in the effect of dexamethasone by diphenylhydantoin. N Engl J Med 281:32\u201334","journal-title":"N Engl J Med"},{"key":"9781_CR14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1474-4422(07)70103-5","volume":"6","author":"MS Breemen van","year":"2007","unstructured":"van Breemen MS, Wilms EB, Vecht CJ (2007) Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol 6:421\u2013430. doi: 10.1016\/S1474-4422(07)70103-5","journal-title":"Lancet Neurol"},{"key":"9781_CR15","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2165\/00003088-200443110-00002","volume":"43","author":"PN Patsalos","year":"2004","unstructured":"Patsalos PN (2004) Clinical pharmacokinetics of levetiracetam. Clin Pharmacokinet 43:707\u2013724. doi: 10.2165\/00003088-200443110-00002","journal-title":"Clin Pharmacokinet"},{"key":"9781_CR16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1345\/aph.1A032","volume":"36","author":"TE Welty","year":"2002","unstructured":"Welty TE, Gidal BE, Ficker DM, Privitera MD (2002) Levetiracetam: a different approach to the pharmacotherapy of epilepsy. Ann Pharmacother 36:296\u2013304. doi: 10.1345\/aph.1A032","journal-title":"Ann Pharmacother"},{"key":"9781_CR17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00007691-200408000-00006","volume":"26","author":"M Contin","year":"2004","unstructured":"Contin M, Albani F, Riva R, Baruzzi A (2004) Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. Ther Drug Monit 26:375\u2013379. doi: 10.1097\/00007691-200408000-00006","journal-title":"Ther Drug Monit"},{"key":"9781_CR18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11060-007-9373-8","volume":"84","author":"HB Newton","year":"2007","unstructured":"Newton HB, Dalton J, Goldlust S, Pearl D (2007) Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors. J Neurooncol 84:293\u2013296. doi: 10.1007\/s11060-007-9373-8","journal-title":"J Neurooncol"},{"key":"9781_CR19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11060-005-9070-4","volume":"78","author":"HB Newton","year":"2006","unstructured":"Newton HB, Goldlust SA, Pearl D (2006) Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. J Neurooncol 78:99\u2013102. doi: 10.1007\/s11060-005-9070-4","journal-title":"J Neurooncol"},{"key":"9781_CR20","doi-asserted-by":"crossref","unstructured":"Maschio M, Albani F, Baruzzi A, Zarabla A, Dinapoli L, Pace A, Pompili A, Carapella CM, Occhipinti E, Jandolo B (2006) Levetiracetam therapy in patients with brain tumour and epilepsy. J Neurooncol 78:157\u2013160","DOI":"10.1007\/s11060-006-9162-9"},{"key":"9781_CR21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1059-1311(03)00096-7","volume":"12","author":"GL Wagner","year":"2003","unstructured":"Wagner GL, Wilms EB, Van Donselaar CA, Vecht ChJ (2003) Levetiracetam: preliminary experience in patients with primary brain tumours. Seizure 12:585\u2013586. doi: 10.1016\/S1059-1311(03)00096-7","journal-title":"Seizure"},{"key":"9781_CR22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0090-3019(81)80054-7","volume":"16","author":"LA Lawson","year":"1981","unstructured":"Lawson LA, Blouin RA, Smith RB, Rapp RP, Young AB (1981) Phenytoin-dexamethasone interaction: a previously unreported observation. Surg Neurol 16:23\u201324. doi: 10.1016\/S0090-3019(81)80054-7","journal-title":"Surg Neurol"},{"key":"9781_CR23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1440-1819.1996.tb01665.x","volume":"50","author":"R Akaho","year":"1996","unstructured":"Akaho R (1996) The effects of antiepileptic drugs on cognition in normal volunteers. Psychiatry Clin Neurosci 50:61\u201369. doi: 10.1111\/j.1440-1819.1996.tb01665.x","journal-title":"Psychiatry Clin Neurosci"},{"key":"9781_CR24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1525-5069(02)00502-9","volume":"3","author":"DL Drane","year":"2002","unstructured":"Drane DL, Meador KJ (2002) Cognitive and behavioral effects of antiepileptic drugs. Epilepsy Behav 3:49\u201353. doi: 10.1016\/S1525-5069(02)00502-9","journal-title":"Epilepsy Behav"},{"key":"9781_CR25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1528-1157.1999.tb00715.x","volume":"40","author":"HJ Mamon","year":"1999","unstructured":"Mamon HJ, Wen PY, Burns AC, Loeffler JS (1999) Allergic skin reactions to anticonvulsant medications in patients receiving cranial radiation therapy. Epilepsia 40:341\u2013344. doi: 10.1111\/j.1528-1157.1999.tb00715.x","journal-title":"Epilepsia"},{"key":"9781_CR26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1212\/WNL.38.2.194","volume":"38","author":"JY Delattre","year":"1988","unstructured":"Delattre JY, Safai B, Posner JB (1988) Erythema multiforme and Stevens-Johnson syndrome in patients receiving cranial irradiation and phenytoin. Neurology 38:194\u2013198","journal-title":"Neurology"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-008-9781-4.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T09:47:53Z","timestamp":1558086473000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-008-9781-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,24]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["9781"],"URL":"https:\/\/doi.org\/10.1007\/s11060-008-9781-4","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,24]]}}}